Accurately detecting and identifying biological warfare agents (BWAs) is the focal point for countering bioterrorism. Current methods used to identify BWAs are primarily focused on a single target agent ([@R1]*--*[@R10]). In contrast, the fiber-optic, microsphere-based, multiplexed arrays described in this paper can rapidly screen and simultaneously identify multiple potential BWAs, enabling an efficient response to a bioterrorism attack. Such multiagent analysis is difficult because it is usually complicated by interferences between assays and the large number of BWA probes.

We developed a platform to simultaneously detect BWAs with an array composed of DNA probe-functionalized microspheres that are randomly distributed onto microwells generated on the end of an etched coherent optical fiber bundle ([@R11]*,*[@R12]) that contains 6,000--50,000 individual fibers. Methods are described more fully in the Appendix. A multiplexed array was fabricated by distributing up to 18 different microsphere sensors into the optical fiber array with species-specific 50-mer DNA probes corresponding to 6 BWAs of interest (*Bacillus anthracis*, *Yersinia pestis*, *Francisella tularensis*, *Brucella melitensis*, *Clostridium botulinum*, and vaccinia virus) and 1 BWA simulant, *Bacillus thuringiensis kurstaki*, with each organism represented by at least 2 probe sequences ([Table A1](#TA.1){ref-type="table"}). All probe sequences were designed with software by Illumina, Inc. (San Diego, CA, USA), and the specificity of the probe sequences was checked against GenBank by using BLAST to have minimal cross-hybridization potential. Employing multiple probes for each BWA reduces the potential for both false-negative and false-positive results in environmental samples. The inherent redundancy of each probe type on the array, because each microsphere type has many replicates, provides additional confidence in detection and enhances the signal-to-noise ratio. Because the assembly process for the arrays is random, each bead type is encoded with an identifying optical bar code ([@R11]*,*[@R12]) created by entrapping dyes in various combinations within microspheres, to differentiate microsphere probe types from one another.

To ensure sensitive detection of BWAs with high accuracy, the performance of this multiplexed, high-density array was assessed by examining the detection limits and specificity of probes with Cy3-labeled synthetic targets (the synthetic target is a 50-mer oligonucleotide complementary to the probe). We modified our previous protocol of microsensor preparation ([@R12]) by using an increased concentration of cyanuric chloride solution in the probe activation step to achieve a more complete and efficient coupling of DNA probes to microspheres. The improved microsensor preparation enabled a detection limit as low as 10 fmol/L (in 50 μL volume) within 30 min hybridization time (data not shown). While the probes were selected to avoid the formation of secondary structures, such structures were not completely eliminated and probably affected the hybridization efficiency, resulting in higher detection limits for some probes on the array. To evaluate probe specificity, arrays containing beads with only a single probe type were exposed sequentially to the synthetic complementary target as well as to all noncomplementary targets. Cross-reactions were observed between probes from the same organism such as BA1/BA2, BA5/BA6, BTK1/BTK2, YP1/YP2, and FT1/FT2 (probes are abbreviated according to the organism from which they were derived: BA, *B. anthracis*; YP, *Y. pestis*; FT, *F. tularensis*; BM, *Brucella melitensis*, CB; *C. botulinum*; VA, vaccinia virus; and BTK, *Bacillus thuringiensis kurstaki*; details in [Table A2](#TA.2){ref-type="table"}) because some of the sequences for each probe pair overlapped, as probes were designed to be specific to the same target gene of the BWA. While in some applications cross-reactions are undesirable, in the present context the cross-reactions between probes from the same BWA confirmed each BWA in the sample. In addition, some minor cross-reactions between probe types from different BWAs were observed because of sequence similarity in spite of the careful probe design for each BWA ([Table A2](#TA.2){ref-type="table"}). These cross-reactions could be advantageous, since they generated a unique response pattern across all the probes on the multiplexed array for each target BWA and provided additional information to identify BWAs. As a result, any BWA can be simultaneously identified with this multiplexed array by looking at the high signals resulting from the specific response of each individual species-specific probe as well as the response pattern across the array.

To sensitively detect target BWAs, polymerase chain reaction (PCR) was used as an amplification step before hybridization on the multiplexed array platform. Amplification was essential, especially when BWAs were present at trace levels in environmental samples (see below). Primer pairs that corresponded to each of the target sequences were designed specifically for each BWA ([Table A1](#TA.1){ref-type="table"}). Each primer pair amplified the respective BWA sequence from an autoclaved bacterial culture ([Table A3](#TA.3){ref-type="table"}) during asymmetric PCR. [Figure 1](#F1){ref-type="fig"} shows the detection of PCR products derived from each individual primer pair based on single bead--type arrays. The variation of the probe responses to PCR products can be explained by the different concentrations of the autoclaved bacterial cultures used as templates in PCR, the varying efficiency of primer pairs, or the potential of PCR products to form secondary structures. While carefully designed and optimized to have PCR products with a shorter length (147--201 bp), some of the amplified PCR fragments might form secondary structures (e.g., BA5). The formation of secondary structures makes the DNA fragments that were complementary to the array probe sequences inaccessible for hybridization. For these targets, the hybridization efficiency was affected, giving low hybridization responses to PCR products. In addition, the position of the target sequences within the PCR amplicons could affect hybridization efficiency. Oligonucleotide probes complementary to the middle part or the 5´ position of PCR products showed lower hybridization efficiencies than did target sequences close to the 3´ positions. This observation was likely related to steric hindrance that led to less accessibility of PCR products to the probe sequences on the array.

![Array detection of single polymerase chain reaction (PCR) products from autoclaved bacterial cultures of the 6 microorganisms listed in [Table A3](#TA.3){ref-type="table"} by using single bead--type arrays. PCR and array hybridization conditions are described in the Appendix. Single bead--type arrays were fabricated containing ≈100 replicates of each microsphere probe. The standard deviation (SD) of background images is 15 (N = 3), and the detection limit is 45, defined as 3 × SD.](05-0269-F1){#F1}

To assess the limit of detection with real bacterial samples, 10-fold serial dilutions were made from the autoclaved cultures of each BWA ([Table A3](#TA.3){ref-type="table"}) and used for PCR followed by array hybridization (summarized in the [Table](#Ta){ref-type="table"}). Specificity tests of primer pairs were performed by applying each primer pair to other nontarget bacterial cultures individually, and no nonspecific amplifications were observed. To investigate the ability to simultaneously detect BWAs, multiplex PCR was used to analyze mixed bacterial cultures that contained multiple BWAs, e.g., *B. anthracis* mixed with *B. thuringiensis kurstaki* and *Y. pestis* mixed with *F. tularensis*, in varying ratios. We prepared 2 primer pools for the 7 BWAs of interest, and each pool contained 1 primer pair specific for each BWA. [Figure 2](#F2){ref-type="fig"} shows the amplification of BWAs in each mixed culture sample using primer pools I and II. The amplified PCR products were subjected to multiplexed array detection with each BWA represented by at least 2 probe types. The [Figure A1](#FA.1){ref-type="fig"} shows the results of simultaneous detection of BWAs in different mixed culture samples after amplification with primer pool I ([Figure A1](#FA.1){ref-type="fig"}, panel A) and pool II ([Figure A1](#FA.1){ref-type="fig"}, panel B). For the mixtures of *B. anthracis* and *B. thuringiensis kurstaki*, both probes BTK1 and BTK2 gave positive signals, as did probes BA1, BA2, and BA4, which indicates the presence of *B. anthracis* and *B. thuringiensis kurstaki*. Since the primer pair specific for *B. anthracis* in primer pool I and pool II corresponded to the BA2 and BA4 sequences, respectively, no positive signals were observed from the other BA probes (BA3, BA5, and BA6); no cross-reactions were seen between them except for probes BA1 and BA2 ([Table A2](#TA.2){ref-type="table"}). For mixtures of *Y. pestis* and *F. tularensis*, differentiating 2 bands ([Figure 2B](#F2){ref-type="fig"}, lane 9 and lane 10) on the gel is difficult because the product size is similar; however, positive signals from the respective probes after hybridization showed these 2 BWAs in the mixed culture samples ([Figure A1](#FA.1){ref-type="fig"}, panel B). Array detection in conjunction with multiplex PCR is advantageous in that it not only simultaneously identifies target BWAs but also minimizes the possibility of misinterpreting PCR results because it adds an additional level of specificity. With gel analysis only, PCR results are usually complicated because of nonspecific amplification during multiplex PCR with environmental samples.

![Gel analysis of multiplex polymerase chain reaction (PCR) with mixed autoclaved bacterial culture samples using primer pool I (A) and II (B). A) Lane 1, DNA ladder; lane 2, *Bacillus anthracis* (BA) + *B. thuringiensis kurstaki* (BTK), 1:1; lane 3, BA + BTK, 1:5; lane 4, BA + BTK, 1:9; lane5, *Yersinia pestis* (YP) + *Francisella tularensis* (FT), 1:1; lane6, YP + FT, 1:9; lane 7, negative control (no template); lane 8, BA-negative control (no template); lane 9, BA-positive control; lane 10, BTK-positive control; lane 11, FT-positive control; lane 12, YP-positive control. B) Lane 1, DNA ladder; lane 2, BA-positive control; lane 3, BTK-positive control; lane 4, BA + BTK, 1:1; lane 5, BA + BTK, 1:5; lane 6, BA + BTK, 1:9; lane 7, FT-positive control; lane 8, YP-positive control; lane 9, YP + FT, 1:1; lane 10, YP + FT, 1:9; lane 11, negative control (no template); lane 12, blank well. Primer pool I contained 7 primer pairs, BA2, BTK1, FT1, YP1, CB1, VA1, and BM1. Primer pool II contained BA4, BTK2, FT2, YP2, CB2, VA2, and BM2. Each primer pool has 1 primer pair for each biological warfare agent of interest. A positive control was run in single PCR with the corresponding primer pair. See Appendix for the conditions of multiplex PCR.](05-0269-F2){#F2}

Since real environmental samples will likely involve complex matrices with many potential interferents, the performance of the multiplexed array was further assessed with wastewater spiked with individual autoclaved bacterial cultures of BWAs at various volumetric dilution factors (1:3 and 1:10) ([Table A3](#TA.3){ref-type="table"}). Both primer pools were applied to all spiked wastewater samples for multiplex PCR. The probes on the multiplexed array gave positive responses only to the amplified PCR products of interest, without responding to any nonspecifically amplified products. [Figure A1](#FA.1){ref-type="fig"}, panel C gives an example of array detection of the amplified BWAs from spiked wastewater samples (1:10 dilution) with primer pool I. BWAs seeded into wastewater at various dilution factors were all identified successfully within 30 minutes of hybridization.

In summary, this fiber-optic, microsphere-based array platform provides fast, sensitive, and simultaneous identification of BWAs with high accuracy. The high density of this array format can accommodate additional probe types while still maintaining a high redundancy for each probe type on the array. Additional probe types could be added to the array without affecting the performance of the existing microspheres. The ability to expand the probe types in the array opens up the opportunity to incorporate a large number of potential BWAs when their genome sequences become available. As a result, the multiplicity of arrays could be increased by incorporating an even broader class of potential BWAs and other pathogens, leading to a universal array for all pathogenic agents of interest.

Appendix
========

Methods
-------

### Single Polymerase Chain Reaction (PCR)

A PCR Master Mix from Promega Corporation (Madison, WI, USA) was applied in all PCR assays. Asymmetric PCR was performed with a reaction mixture containing 2.5 U Taq DNA polymerase, a 200-μmol/L concentration of each deoxynucleoside triphosphate (dATP, dGTP, dCTP, and dTTP), 1.5 mmol/L MgCl~2~ in 1´ reaction buffer, 500 nmol/L Cy3 modified reverse primer, 50 nmol/L forward primer, and 10 μL DNA template from the autoclaved bacterial cultures. The amplification profile included an initial step at 95°C for 5 min, followed by 5 cycles of 95°C for 1 min, 56°C for 1 min, and 72°C for 1 min; 30 cycles of 95°C for 1 min, 54°C for 1 min, and 72°C for 1 min; and a final extension step at 72°C for 7 min. PCR controls were run with the reaction containing all the reagents for PCR amplification except template DNA.

### Multiplex PCR

Primer pool I contained 7 primer pairs, BA2, BTK1, FT1, YP1, CB1, VA1, and BM1. Primer pool II contained BA4, BTK2, FT2, YP2, CB2, VA2, and BM2. Each primer pool has 1 primer pair for each biological warfare agent of interest. Multiplex PCR was run as follows: an initial step at 95°C for 5 min, followed by 5 cycles of 95°C for 1 min, 56°C for 1 min, and 72°C for 1 min; 40 cycles of 95°C for 1 min, 54°C for 1 min, and 72°C for 1 min; and a final extension step at 72°C for 7 min. PCR products were analyzed on 4% precast agarose gels (Invitrogen Corporation, Carlsbad, CA, USA) and visualized on Gel Doc XR System (Bio-Rad Laboratories, Hercules, CA, USA).

PCR products were denatured at 95°C for 5 min and chilled on ice. The denatured PCR products (25 μL) were combined with 10 μL hybridization buffer (2 mol/L NaCl and 0.2 mol/L phosphate-buffered saline \[PBS\]) and hybridized to the multiplexed array for 30 min at room temperature. Tris-EDTA (TE) buffer was used to wash the array after hybridization to remove the unbound target DNA, and 20% formamide in PBS (50°C) was applied for 1 min to minimize nonspecific binding of target DNA to probes followed by washing with TE buffer for another 1 min.

*Suggested citation for this article*: Song L, Ahn S, Walt DR. Detecting biological warfare agents. Emerg Infect Dis \[serial on the Internet\]. 2005 Oct \[*date cited*\]. <http://dx.doi.org/10.3201/eid1110.050269>
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###### Sequence information of probes and primer pairs\* ([Download PDF](wwwnc.cdc.gov/eid/pdfs/05-0269-TA1.pdf) \[47 KB, 1 page\])

  Organism                                                                                                                   Target gene                               Accession no.                                                                                                              Probe sequences and primer sequences (5'-3')                                                                                PCR product (bp)   Name
  -------------------------------------------------------------------------------------------------------------------------- ----------------------------------------- -------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------- ------------------ ------
  *Bacillus anthracis*                                                                                                       *capA*                                    M24150                                                                                                                     P: 5´-CCGAGTCCTAGACAGGAAGCCTTAGCAAAAGCAATGGTTGATGCAGGGGC-3´ F: 5´-GGGGGGAAGAATACGATAAT-3´; R: 5´-GTTCTTGTCCATCCTTGGTC-3'    188                BA1
  P: 5´-ACGCACTGGGGGGAAGAATACGATAATAAACCGAGTCCTAGACAGGAAGC-3´ F: 5´-TAGTAAATACGCACTGGGTT-3´; R: 5'-CATCCTTGGTCAAACACAAA-3´   194                                       BA2                                                                                                                                                                                                                                                                       
  *pagA*                                                                                                                     M22589                                    P: 5´-GGAAGAGTGAGGGTGGATACAGGCTCGAACTGGAGTGAAGTGTTACCGCA-3´ F: 5´-AAAATGGAAGAGTGAGGGTG-3´; R: 5´-CCGCCTTTCTACCAGATTTA-3´   120                                                                                                                         BA3                
  P: 5´-TGTATCACCAGAGGCAAGACACCCCCTTGTGGCAGCTTATCCGATTGTAC-3´ F: 5´-TGTATCACCAGAGGCAAGAC-3´; R: 5´-TTCTGTGTGGATTGATCCTC-3´   106                                       BA4                                                                                                                                                                                                                                                                       
  *SASP-B*                                                                                                                   AF359938                                  P: 5´-GAAGCTAAGAAAGCGCAAGCTTCTGGTGCTAGATTCAAAGCACAAATGC-3´ F: 5´-GTAAAACAAGCAAACGCACA-3´; R: 5´-GATTGTGATTGTTTTGCAGC-3´    162                                                                                                                         BA5                
  P: 5´-CAAGCAGTAAAACAAGCAAACGCACAATCAGAAGCTAAGAAAGCGCAAGC-3´ F: 5´-TTTGCGACTGAAACAAATGT-3´; R: 5´-ATGCACGTCTGTTTCAGTTG-3´   142                                       BA6                                                                                                                                                                                                                                                                       
  *Brucella melitensis*                                                                                                      Sequence between BMEI1658 and BMEI1659†   AE009601                                                                                                                   P: 5´-AGGTGTCATTAGGCTTGCTTGTGGACGAGAGAACGGTGGACCAAGGGAGA-3´ F: 5´-TCCGAGGGTAAACACCTAAG-3´; R: 5´-ACTCACGGACAGCATTAGGT-3´    181                BM1
  P: 5´-CTCTCACGGTCCCCATAATGGAGAGTGATCCGAGGGTAAACACCTAAGGG-3´ F: 5´-TCTCTCACGGTCCCCATAAT-3´; R: 5´-AGCAAGCCTAATGACACCTT-3´   147                                       BM2                                                                                                                                                                                                                                                                       
  *Clostridium botulinum*                                                                                                    Random chromosomal DNA fragment‡          NA                                                                                                                         P: 5´- CATCTTCACGGAGGTGAACAAGCCTCCATGTTCGACGGTAACCCAGAAGC-3´ F: 5´-AGATCAGAAGGATGTACCGC-3´; R: 5´-ACTCTTGGACATTGGGGTAA-3´   173                CB1
  P: 5´-CCACCGGGAGTGCCGGAAGATCAGAAGGATGTACCGCTAGTAACTCATCT-3´ F: 5´-AATAATACGCCTATGACGCC-3´; R: 5´-TAAACCTTTTGCTGTCCACC-3´   163                                       CB2                                                                                                                                                                                                                                                                       
  *Yersinia pestis*                                                                                                          Plasminogen activator                     M27820                                                                                                                     P: 5´-GGACGTCTCTGGCTTCCGGGTCAGGTAATATGGATGACTACGACTGGATG-3´ F: 5´-CAAAAATGTCGCTATCCTGA-3´; R: 5´-GGTCATATTCATTGGCATGA-3´    201                YP1
  P: 5´-TCCATACTCATTTCTGACCCTGAATGCCAGGGGGTGGACGTCTCTGGCTT-3´ F: 5´-ACGCAGAAACAGGAAGAAAG-3´; R: 5´-CATCCAGTCGTAGTCATCCA-3´   168                                       YP2                                                                                                                                                                                                                                                                       
  *Bacillus thuringiensis kurstaki*                                                                                          *cry1A*                                   AY225453                                                                                                                   P: 5´-TGGTCAGGGCATCAAATAATGGCTTCTCCTGTCGGTTTTTCGGGGCCAGA-3' F: 5´-TATTATTGGTCAGGGCATCA-3´; R: 5´-GTTCTATACACGCCCTGACC-3´    144                BTK1
  P: 5´-GGTAGTTTTCGAGGCTCGGCTCAGGGCATAGAAAGAAGTATTAGGAGTCC-3´ F: 5´-TGATGGTAGTTTTCGAGGCT-3´; R: 5´-CGACAGGAGAAGCCATTATT-3´   153                                       BTK2                                                                                                                                                                                                                                                                      
  Vaccinia virus                                                                                                             Thymidine kinase                          U94848                                                                                                                     P: 5´-CGTATGGCAAACGAAGGAAAAATAGTTATAGTAGCCGCACTCGATGGGAC-3´ F: 5´-ATTCTGTGAGCGTATGGCAA-3´; R: 5´-TCTATCTCGGTTTCCTCACC-3´    199                VA1
  P: 5´-GGCGGACATATTCAGTTGATAATCGGCCCCATGTTTTCAGGTAAAAGTAC-3´ F: 5´-GGCGGACATATTCAGTTGAT-3´; R: 5´-GCTTCCAATGCTTCAAAATT-3´   183                                       VA2                                                                                                                                                                                                                                                                       
  *Francisella tularensis*                                                                                                   *fopA*                                    AF097542                                                                                                                   P: 5´-GGTTCAGCTACAGCATCTATCGCTGCAGGTTCAGATAATATCGATACATC-3´ F: 5´-TTAGGTTCAGCTACAGCATC-3´; R: 5´-TGTCCTTGTTAGTCAAAGCG-3´    155                FT1
  P: 5´-CATCAGCAAACACTAATTCAGCTACTACACAAAGCAGTGGTTTTGCAGCT-3´ F: 5´-TCAGCTACAGCATCTATCGC-3´; R: 5'-TGTCCTTGTTAGTCAAAGCG-3'   149                                       FT2                                                                                                                                                                                                                                                                       

\*P, probe; F, forward primer; R, reverse primer; NA, not applicable. All sequences were purchased from Integrated DNA Technologies, Inc. (Coralville, IA, USA). Probe sequences were modified with an amine group and C6 linker at the 5´ position, and these were used to immobilize the probe on microspheres. Synthetic complementary targets of probes and reverse primers were modified with Cy3 at 5´ position as a reporter for array hybridization. †Sequences are from the noncoding region between 2 open reading frames, BMEI1658 and BMEI1659. ‡Sequences were obtained by sequencing by the collaborator and are not available from GenBank.

###### Cross-reactions between 18 probes on the multiplexed array\* ([Download PDF](wwwnc.cdc.gov/eid/pdfs/05-0269-TA2.pdf)\[93 KB, 1 page\])

  Targets (100 nmol/L)   Probes                                                                                                                                                                                                           
  ---------------------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- ------------ ------------ ------------ ----------- ------------ ------------ ----------- ----------- ----------- -----------
  BA1                    **808.1**   **173.4**   13.8        14.5        18.1        9.61        17.1        9.75        21.1         21.3         22.2         27.9        31.8         29.2         30.8        27.4        30.1        27.2
  BA2                    **712.3**   **701.2**   15.1        18.1        9.57        --0.28      11.9        --1.54      25.8         15.6         19.8         13.4        15.2         32.5         10.5        5.2         21.6        23.1
  BA3                    9.61        13.4        **457.4**   6.48        6.15        7.6         12.4        11.4        --2.69       13.9         5.56         6.66        11.3         24.1         8.61        --2.84      29.8        16.9
  BA4                    11.7        20.8        26.9        **693.2**   26.6        8.61        20.3        25.5        31.6         14.4         5.65         9.05        19.6         21.6         17.9        31.1        19.8        25.6
  BA5                    10.9        2.4         5.7         14.2        **410.3**   **113.6**   10.7        2.2         12.6         19.8         25.7         30.1        --1.6        21.7         28.2        25.8        30.1        8.78
  BA6                    17.7        --3.45      11.3        15.5        **262.8**   **853.9**   17.5        31.6        29.9         11.4         33.6         32.2        24.8         27.6         30.9        11.9        13.7        31.4
  BM1                    7.92        3.32        23.2        --3.22      18.8        11.5        **723.5**   --4.28      32.2         --4.99       20.8         25.8        18.2         17.3         29.3        27.9        25.9        14.6
  BM2                    3.08        3.84        26.8        6.78        3.96        5.67        24.1        **973.3**   21.3         1.11         15.9         17.6        19.9         32.8         13.9        24.4        34.4        12.9
  BTK1                   14.1        6.1         30.4        6.35        15.6        9.77        17.1        6.05        **1423.1**   **232.8**    32.4         19.2        19.7         12.5         16.6        26.3        8.95        23.1
  BTK2                   27.7        --0.91      3.39        6.8         8.39        4.56        10.3        9.59        **425.8**    **1288.6**   22.1         8.16        9.8          18.9         28.2        19          7.84        19.4
  YP1                    12.5        --0.79      28          4.56        12.5        5.11        8.88        20.6        12.9         32.1         **2089**     **588.7**   23.6         24.6         **179.7**   25.7        15.9        29.2
  YP2                    23.4        32.1        23.6        14.2        --1.58      29.3        15.4        19.1        28.1         23.8         **1491.5**   **1784**    14.5         11.3         9.7         7.05        23.9        14.6
  VA1                    8.9         24.9        25.3        4.71        8.61        18.7        13.6        8.61        3.12         9.87         12.7         16.6        **1536.9**   1.75         25.4        23.8        17.7        11.8
  VA2                    43.1        15.9        4.59        8.94        7.18        23.2        29.4        3.25        15.4         14.7         26.7         12          18.3         **1703.4**   23.9        --0.76      26.3        29.7
  FT1                    19.8        19.7        8.77        25.6        14.6        4.65        32.1        14.7        6.96         1.56         14.9         0.65        0.56         0.78         **793**     26.8        28.5        20.5
  FT2                    25.4        8.4         11.5        16.9        19.7        7.98        9.94        17.9        12.5         25.1         4.44         14.5        8.3          13.4         **216.7**   **456.9**   8.99        27.9
  CB1                    23.1        5.68        16.9        20.1        27.2        15.3        14.1        9.11        7.46         16.1         4.6          19          28.3         **171.6**    4.93        24.8        **843.1**   18.5
  CB2                    14.8        11.2        8.45        8.16        5.45        24.6        20.9        3.25        1.62         21.9         25.8         23.5        13.3         18.0         28.2        21.2        **89.1**    **592.1**

\*The numbers are net fluorescence intensities (in arbitrary units) obtained by subtracting the average intensity value of the background from that of the hybridization signal. The specific response for each probe is indicated in **red**. The cross responses between probes designed for the same biological warfare agent (BWA) are indicated in **pink**, and the cross-reactions between probes from different BWAs are marked with **blue**. The standard deviation (SD) of background is 15 (n = 3), and the detection limit of array hybridization for each microsphere probe is 45, defined as 3 × SD.

###### Number of microorganisms in autoclaved bacterial cultures used as templates in polymerase chain reaction; cultures were also used to spike wastewater and prepare mixed bacterial samples\*

  Organism                            DNA copies/mL
  ----------------------------------- ---------------
  *Bacillus thuringiensis kurstaki*   2.4 × 10^8^
  *B. anthracis* Ames                 1.2 × 10^5^
  Vaccinia virus                      7.7 × 10^6^
  *Yersinia pestis* CO-92             2.8 × 10^5^
  *Clostridium botulinum* A           3.1 × 10^7^
  *Francisella tularensis* Novicida   1.1 × 10^6^

\*Naval Medical Research Command (NMRC) did not provide an autoclaved bacterial culture of *Brucella melitensis*; therefore, no results were obtained for *Brucella melitensis* other than with synthetic target sequences. The numbers provided by NMRC in this table are based on real- time polymerase chain reaction quantification, where a standard curve was produced with cloned material and used to calculate the results of a gene copy/mL quantification of the autoclaved material.

![Simultaneous array detection of biological warfare agents in mixed autoclaved bacterial culture samples amplified with primer pool I (A), primer pool II (B), and wastewater samples spiked with primer pool I (C). Mixed samples were prepared by mixing Bacillus anthracis with B. thuringiensis kurstaki at 1:1, 1:5 and 1:9 ratios and Yersinia pestis with Francisella tularensis at 1:1 and 1:9 ratios. Wastewater samples were prepared by spiking individual autoclaved bacterial cultures of B. anthracis, B. thuringiensis kurstaki, Y. pestis, F. tularensis, Clostridium botulinum, and vaccinia virus at 1:10 dilution. The standard deviation (SD) of background images is 15 (n = 3), and the detection limit is 45, defined as 3 × SD.](05-0269-FA1){#FA.1}

###### Detection limits of real samples determined with polymerase chain reaction followed by array detection

  Organism                      DNA copies/mL
  ----------------------------- ---------------
  *Bacillus anthracis*          10^3^
  *B. thuringiensis kurstaki*   10^2^
  Vaccinia virus                10^2^
  *Yersinia pestis*             10^2^
  *Francisella tularensis*      10^3^
  *Clostridium botulinum*       10^3^
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